Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 4,100 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Perez sold 4,100 shares of the business’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $100.20, for a total value of $410,820.00. Following the transaction, the chief executive officer directly owned 4,100 shares of the company’s stock, valued at $410,820. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Thursday, September 10th, Daniel Perez sold 150,000 shares of Hinge Health stock. The stock was sold at an average price of $89.44, for a total value of $13,416,000.00.
• On Thursday, September 10th, Daniel Perez sold 100,000 shares of Hinge Health stock. The stock was sold at an average price of $89.45, for a total value of $8,945,000.00.

Hinge Health Price Performance

HNGE stock opened at $98.00 on Friday. The company has a market cap of $7.91 billion, a price-to-earnings ratio of 76.56 and a beta of 1.37. The company has a fifty day moving average price of $90.69 and a 200 day moving average price of $70.98. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $100.36.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.28 by $0.31. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.The business had revenue of $212.82 million during the quarter. During the same period in the prior year, the business earned $0.59 earnings per share. The firm’s quarterly revenue was up 53.0% compared to the same quarter last year. As a group, analysts anticipate that Hinge Health Inc. will post 1.25 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have commented on the company. KeyCorp lifted their price target on Hinge Health from $90.00 to $125.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Citizens Jmp boosted their target price on shares of Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a report on Wednesday, August 5th. Royal Bank Of Canada upped their price target on Hinge Health from $75.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Wall Street Zen downgraded shares of Hinge Health from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Raymond James Financial upped their price target on Hinge Health from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $105.33.

Institutional Investors Weigh In On Hinge Health

Hedge funds have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC grew its position in shares of Hinge Health by 60.1% during the third quarter. Farther Finance Advisors LLC now owns 9,066 shares of the company’s stock worth $882,000 after acquiring an additional 3,403 shares during the last quarter. Vista Investment Partners LLC grew its position in Hinge Health by 29.3% in the 3rd quarter. Vista Investment Partners LLC now owns 54,021 shares of the company’s stock worth $5,252,000 after purchasing an additional 12,232 shares during the last quarter. MRA Advisory Group acquired a new stake in shares of Hinge Health in the third quarter valued at approximately $755,000. Argent Capital Management LLC bought a new stake in shares of Hinge Health during the third quarter valued at approximately $3,376,000. Finally, Tidal Investments LLC bought a new stake in shares of Hinge Health during the second quarter valued at approximately $925,000.

About Hinge Health

Hinge Health, Inc is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California.